Sato Eiichi, Togawa Atsushi, Masaki Michio, Shirahashi Akihiko, Kumagawa Midori, Kawano Yasumasa, Ishikura Hiroyasu, Yamashiro Yuri, Takagi Satoshi, To Hiromi, Kobata Katsumi, Takeshita Morishige, Kusaba Koji, Sueoka Eisaburo, Tamura Kazuo, Takamatsu Yasushi, Takata Tohru
Division of Medical Oncology, Hematology, and Infectious Diseases, Department of Internal Medicine, Fukuoka University Hospital, Japan.
Department of Blood Transfusion, Fukuoka University Hospital, Japan.
Intern Med. 2019 Mar 15;58(6):877-882. doi: 10.2169/internalmedicine.1706-18. Epub 2018 Nov 19.
We herein report a case of systemic phaeohyphomycosis by Exophiala dermatitidis (E. dermatitidis) with chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). The patient had been taking oral corticosteroids for years to control the GVHD. Yeast-like fungi were identified in a blood culture, so treatment with micafungin (150 mg/day) was begun, with no improvement. The patient passed away on hospital Day 12. A sequence analysis of rRNA revealed the isolate to be E. dermatitidis. This report brings attention to an emerging mycosis of community-acquired Exophiala species infection in the very-late phase after allogenic HSCT in patients with chronic GVHD.
我们在此报告1例异体造血干细胞移植(HSCT)后发生慢性移植物抗宿主病(GVHD)并由皮炎外瓶霉(E. dermatitidis)引起系统性暗色丝孢霉病的病例。该患者多年来一直口服皮质类固醇以控制GVHD。血培养中鉴定出酵母样真菌,因此开始用米卡芬净(150mg/天)治疗,但无改善。患者于住院第12天死亡。rRNA序列分析显示分离株为皮炎外瓶霉。本报告提醒人们注意在慢性GVHD患者异体HSCT极晚期出现的社区获得性外瓶霉属真菌感染这一新兴真菌病。